JP2013525388A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013525388A5 JP2013525388A5 JP2013506514A JP2013506514A JP2013525388A5 JP 2013525388 A5 JP2013525388 A5 JP 2013525388A5 JP 2013506514 A JP2013506514 A JP 2013506514A JP 2013506514 A JP2013506514 A JP 2013506514A JP 2013525388 A5 JP2013525388 A5 JP 2013525388A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- unsaturated
- tetrapeptide
- cosmetic use
- conh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920006395 saturated elastomer Polymers 0.000 claims description 16
- 239000002537 cosmetic Substances 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 8
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
- -1 isopropynyl Chemical group 0.000 claims description 8
- 125000005645 linoleyl group Chemical group 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 4
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims description 4
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 125000003977 lipoyl group Chemical group S1SC(C([H])([H])C(C(C(C(=O)[*])([H])[H])([H])[H])([H])[H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 claims description 4
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 208000001840 Dandruff Diseases 0.000 claims description 2
- 101150020584 GLRX2 gene Proteins 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 230000003712 anti-aging effect Effects 0.000 claims description 2
- 230000001166 anti-perspirative effect Effects 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 239000003213 antiperspirant Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000002781 deodorant agent Substances 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 230000014509 gene expression Effects 0.000 claims description 2
- 239000003752 hydrotrope Substances 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 150000003904 phospholipids Chemical class 0.000 claims description 2
- 230000003711 photoprotective effect Effects 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 230000037394 skin elasticity Effects 0.000 claims description 2
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 102000015225 Connective Tissue Growth Factor Human genes 0.000 claims 2
- 108010039419 Connective Tissue Growth Factor Proteins 0.000 claims 2
- 102100033167 Elastin Human genes 0.000 claims 2
- 108010014258 Elastin Proteins 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 239000001993 wax Substances 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 102000012422 Collagen Type I Human genes 0.000 claims 1
- 108010022452 Collagen Type I Proteins 0.000 claims 1
- 102100027442 Collagen alpha-1(XII) chain Human genes 0.000 claims 1
- 102100024203 Collagen alpha-1(XIV) chain Human genes 0.000 claims 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 1
- 101000861874 Homo sapiens Collagen alpha-1(XII) chain Proteins 0.000 claims 1
- 101000909626 Homo sapiens Collagen alpha-1(XIV) chain Proteins 0.000 claims 1
- 230000006851 antioxidant defense Effects 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 239000007854 depigmenting agent Substances 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 229920002549 elastin Polymers 0.000 claims 1
- 210000002744 extracellular matrix Anatomy 0.000 claims 1
- 239000003925 fat Substances 0.000 claims 1
- 239000000077 insect repellent Substances 0.000 claims 1
- 239000003607 modifier Substances 0.000 claims 1
- 101150021123 msrA gene Proteins 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 210000004927 skin cell Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10161397A EP2382963A1 (en) | 2010-04-29 | 2010-04-29 | Cosmetic composition containing oligopeptides |
| EP10161397.4 | 2010-04-29 | ||
| PCT/EP2011/001099 WO2011134568A1 (en) | 2010-04-29 | 2011-03-05 | Cosmetic composition containing oligopeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013525388A JP2013525388A (ja) | 2013-06-20 |
| JP2013525388A5 true JP2013525388A5 (enExample) | 2014-04-17 |
| JP5858985B2 JP5858985B2 (ja) | 2016-02-10 |
Family
ID=42830791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506514A Expired - Fee Related JP5858985B2 (ja) | 2010-04-29 | 2011-03-05 | オリゴペプチド含有化粧品組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8815814B2 (enExample) |
| EP (2) | EP2382963A1 (enExample) |
| JP (1) | JP5858985B2 (enExample) |
| KR (1) | KR20130067249A (enExample) |
| CN (1) | CN102869339B (enExample) |
| WO (1) | WO2011134568A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3012811B1 (fr) * | 2013-11-05 | 2015-12-25 | Basf Beauty Care Solutions France Sas | Oligopeptides et leurs utilisations |
| KR20230125097A (ko) | 2014-12-04 | 2023-08-28 | 마리 케이 인코포레이티드 | 트리플루오로아세틸 트리펩타이드-2를 포함하는 국소피부 케어 조성물 |
| GB2548775B (en) | 2014-12-29 | 2020-09-02 | Kimberly Clark Co | Cosmetic emulsions |
| US10406081B2 (en) | 2014-12-29 | 2019-09-10 | Kimberly-Clark Worldwide, Inc. | Multifunctional base emulsion |
| US9762164B2 (en) * | 2015-09-18 | 2017-09-12 | Faraday & Future Inc. | Methods and apparatus for generating current commands for an interior permanent magnet (IPM) motor |
| CN109512710A (zh) | 2017-09-18 | 2019-03-26 | 玫琳凯有限公司 | 化妆品组合物及方法 |
| CN111840124A (zh) * | 2020-08-03 | 2020-10-30 | 广州市丽泽化妆品有限公司 | 寡肽水感靓肤面膜及其精华液及精华液的制备方法 |
| EP4000598A1 (en) * | 2020-11-17 | 2022-05-25 | The Boots Company plc | Tetrapeptide and compositions comprising tetrapeptides |
| EP4000597A1 (en) * | 2020-11-17 | 2022-05-25 | The Boots Company plc | Tetrapeptide and compositions comprising tetrapeptides |
| EP4000596A1 (en) * | 2020-11-17 | 2022-05-25 | The Boots Company plc | Tetrapeptide and compositions comprising tetrapeptides |
| CN118141709B (zh) * | 2024-02-22 | 2025-04-22 | 北京逆之龄生物科技有限公司 | 一种抗衰老化妆品及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU68901A1 (enExample) | 1973-11-30 | 1975-08-20 | ||
| US4966848A (en) * | 1988-02-08 | 1990-10-30 | The General Hospital Corporation | Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase |
| US5223421A (en) * | 1989-10-25 | 1993-06-29 | The General Hospital Corporation | Identification of methionine Nα-acetyltransferase |
| US5688489A (en) * | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| JPH10265400A (ja) * | 1997-03-19 | 1998-10-06 | Shigeaki Ishizaka | ペプチドと薬剤 |
| DE19756377A1 (de) | 1997-12-18 | 1999-06-24 | Beiersdorf Ag | Verwendung von C¶1¶¶8¶-¶3¶¶8¶-Alkylhydroxystearoylstearat zur Verstärkung der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen |
| FR2783169B1 (fr) | 1998-09-15 | 2001-11-02 | Sederma Sa | Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution) |
| KR101045658B1 (ko) | 2003-11-17 | 2011-07-01 | 쎄데르마 | 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물 |
| US7566464B2 (en) | 2005-09-01 | 2009-07-28 | Belfer William A | Cosmetic composition to accelerate repair of functional wrinkles |
| JP5587772B2 (ja) * | 2007-06-27 | 2014-09-10 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | オリゴペプチドチロシナーゼインヒビターおよびその使用 |
| EP2065029B1 (en) | 2007-11-30 | 2013-04-17 | Evonik Goldschmidt GmbH | Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K |
-
2010
- 2010-04-29 EP EP10161397A patent/EP2382963A1/en not_active Withdrawn
-
2011
- 2011-03-05 JP JP2013506514A patent/JP5858985B2/ja not_active Expired - Fee Related
- 2011-03-05 WO PCT/EP2011/001099 patent/WO2011134568A1/en not_active Ceased
- 2011-03-05 KR KR1020127026750A patent/KR20130067249A/ko not_active Withdrawn
- 2011-03-05 CN CN201180021577.5A patent/CN102869339B/zh not_active Expired - Fee Related
- 2011-03-05 EP EP11707101A patent/EP2563324A1/en not_active Withdrawn
- 2011-03-05 US US13/643,659 patent/US8815814B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013525388A5 (enExample) | ||
| EP2311452B2 (en) | Topical composition comprising n-acetyl glucosamine | |
| JPWO2020166678A1 (ja) | 化粧料配合剤および化粧料並びにその製造方法 | |
| US9962354B2 (en) | Method and composition for bacterial or fungal suppression on skin | |
| KR101786913B1 (ko) | 피부개선물질의 피부투과를 증가시키는 화장료 조성물 | |
| CN1177579C (zh) | 皮肤及毛发制剂 | |
| RU2005134130A (ru) | Трипептиды и их производные для косметического применения для улучшения структуры кожи | |
| JP2008120811A (ja) | 抗菌組成物 | |
| JP2001026514A (ja) | 痩せるための化粧品組成物 | |
| WO2005023750A3 (en) | Branched ester composition | |
| FR2997852A1 (fr) | Composition cosmetique contenant un acetate d'un compose d'aminoacide. | |
| EP2675825A1 (fr) | Nouveaux peptides activateurs de la synthese des proteines de la matrice extracellulaire et compositions cosmetiques les comprenant | |
| EP2117498A2 (en) | Use of derivatives of 4-hydroxyphenoxy acetic acid | |
| JP5843853B2 (ja) | 局所用パルミトイルグルタチオン製剤 | |
| JP2013528176A (ja) | 局所用アシルグルタチオン製剤 | |
| CN117203302A (zh) | 使用了氨基酸和羧酸的配合物、有机盐和包含它们的组合物及其用途 | |
| JP6852261B2 (ja) | アシル塩基性アミノ酸誘導体および生理活性物質を含むマルチラメラベシクル製剤 | |
| JP2001510784A (ja) | 化粧品用配合物におけるリポアミノ酸の使用 | |
| FR3060328A1 (fr) | Agent cosmetique ayant un effet ameliore contre les odeurs corporelles | |
| JP2021172587A (ja) | 水中油型乳化化粧料 | |
| JP2008088129A (ja) | 水中油型乳化化粧料 | |
| KR102209574B1 (ko) | 싸이올 화합물 소취용 조성물 | |
| JP6179771B2 (ja) | 新規デルマトポンチン活性化ペプチド及びそれを包含する化粧品組成物 | |
| EP2705050A1 (fr) | Nouveaux peptides modulateurs de la proteine trf2 et compositions les comprenant | |
| WO2022230959A1 (ja) | シワ改善のための皮膚外用剤 |